Clinical trials help develop doctors create tomorrow's cures today. A clinical trial takes place when scientific research is applied to human health. When this occurs, the research hypotesis that was successful in a laboratory setting is applied to patients. Participating in trials is always optional. The following links provide additional information about participating in clinical trials.
Inova Heart and Vascular Institute Cardiac Research Database
Niv Ad, MD
Enrolling
In Vitro Proteomic Analysis of Blood Samples Isolated from Vascular Intervention Patients - Coronary Sinus Project
Niv Ad, MD
Enrolling
In Vitro Proteomic Analysis of Blood Samples Isolated from Vascular Intervention Patients - Carotid Artery Project
Niv Ad, MD
Enrolling
In Vitro Proteomic Analysis of Atheromatous Plaque
Niv Ad, MD
Enrolling
In Vitro Proteomic Analysis of Diseased Aortic Valves
Niv Ad, MD
Enrolling
Health Related Quality of Life (HQRL) for Maze Patients from 09/2004
Niv Ad, MD
Enrolling
In-Vitro Analysis of the Effectiveness of a New Class of Agents that Target Sites of Vascular Damage.
Niv Ad, MD
Enrolling
Understanding the Cardiac Cell Functioning in Successful Outcomes from the Maze Surgical Procedure for Atrial Fibrillation as Verified by Long-Term Monitoring
Niv Ad, MD
Enrolling
Obesity and Obstructive Sleep Apnea as Risk Factors for the Recurrence of Atrial Fibrillation after Implementation of the Maze Procedure for Atrial Fibrillation
Niv Ad, MD
Enrolling
The Prevalence of Subclavian Stenosis 5 years Post Coronary Artery Bypass Surgery
Niv Ad, MD
Enrolling
CARPENTIER-EDWARDS PERIMOUNT MAGNA PERICARDIAL BIOPROSTHESIS in the AORTIC POSITION, MODEL 3000TFX
Niv Ad, MD
Enrolling
ABLATE Trial Atricture Synergy Bipolar RF Energy Lesions for Permanent Atrial Fibrillation treatment during Concomitant On-Pump Endo/Epicardial Cardiac Surgery
Niv Ad, MD
Enrolling
Medtronic Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation (CURE-AF) Study
Niv Ad, MD
Enrolling
Medtronic Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation/Persistent (CURE-AF/Persistent) Study
Niv Ad, MD
Enrolling
Impact of the Bispectral Monitor (BIS) on the Extubation of the Cardiovascular Surgical Patients.
Jennifer Anderson, RN
Enrolling
The Level of Pain Control Achieved with the On-Q Pain Pump as Compared to Traditional Pain Control Measures After Cardiac Surgery
Linda Henry, PhD
Enrolling
Patient Perceptions of New Technologies for Collecting Health-Related Quality of Life Information Before and After Cardiac Surgery
Lisa Martin, PhD
Enrolling
A Pilot Study to Determine the Health-Related Quality of Life (HRQL) Questions to Ask Cardiac Surgery Patients and to Assess the Feasibility of Administering the Questions through Computer Adaptive Testing (CAT) (IRC # CVA080301U
Lisa Martin, PhD
Enrolling
Examining Gender Differences in the Cardiac Surgery Experience and in Health-Related Quality of Life Measurement
Lisa Martin, PhD
Enrolling
Assessing the Long-Term Health-Related Quality of Life in the Cardiac Surgery Patient Post-Surgery: How Long is "Long-Term"?
Lisa Martin, PhD
Enrolling
Health-Related Quality of Life in Coronary Artery Bypass Grafting Patients
Lisa Martin, PhD
Enrolling
The Impact of the Implementation of the Hospital Anxiety and Depression Scale (HADS), Patient Expectations & Satisfaction, and Atrial Fibrillation Severity Scale Instruments into an Existing Long-Term Follow-Up Protocol for Cardiac Surgery Patients
Lisa Martin, PhD
Enrolling
Incision Infection Merck V710 Staph Vax
Anthony Rongione, MD
Enrolling
Virginia Cardiac Surgery Quality Initiative's Multi-Center Red Blood Cell Transfusion Study.
Alan Speir, MD
Enrolling
RIFLE Classification of Acute Renal Failure following CABG
Henry Tran, MD
Enrolling
Association between Statins and Maintenance of Sinus Rhythm Following MAZE Surgery
Henry Tran, MD
Enrolling
Completed Trials
Government
Listing
Name and Location
Opening Date
Closing Date
538.A
Avant Immunotherapeutics | TP10-ACS-002 | Avant Woman:
"TP10-ACS-002; A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Human Recombinant Soluble Complement Receptor Type 1 (TP10) in Adult Women Undergoing Cardiopulmonary Bypass Surgery"
02-01-04
31-08-05
539.A
Scios | A014 | Natrecor:
“A Pilot Multicenter Randomized Double-blind, Placebo-controlled Study to Evaluate Nesiritide Infusion Initiated Post-induction of Anesthesia in the management of Coronary Artery Bypass Graft (CABG) Patients requiring Cardiopulmonary Bypass (CPB)”
03-12-03
20-05-05
596.C
Proctor & Gamble | 2003141 | PRIMO II:
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of 2 mg/kg Bolus Plus 24-hour 0.05 mg/kg/hr Infusion of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass (PRIMO-CABG II)
30-03-04
01-07-05
627.B
NABI BioPharm | NABI 1366 | NABI 1366-staphvax :
A Multicenter, Randomized, Placebo-Controlled, Double-Blinded Study to Evaluate Safety and Immunogenicity of StaphVAX®, a Bivalent Staphylococcus aureus Glycoconjugate Vaccine, in Adult Patients Undergoing Cardiovascular Surgery
21-04-01
28-03-05
894.B
Medicure | 06004 | MEND CABG ph III:
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY TO EVALUATE THE CARDIOPROTECTIVE EFFECTS OF MC-1 IN PATIENTS UNDERGOING HIGH-RISK CORONARY ARTERY BYPASS GRAFT (CABG) SURGERY
“A Phase II Study Designed to Evaluate the Safety, Tolerability, and Effect of a Single, Rising Dose of Intravenous AL-208, Followed by a Placebo-Controlled, Double-Blind, Parallel-Group Evaluation of a Single Dose of AL-208, on Mild Cognitive Impairment Following Coronary Artery Bypass Graft Surgery
06-06-06
01-06-07
142.E
Pharmacia & Upjohn | PARA-0505-071 | PAIN:
"A Double Blind Multicenter Study of the Safety and Efficacy of Paracoxib Followed by Valdecoxib Compared to Placebo for Treatment of Post-Surgical Pain in Patients who Have Coronary Bypass Graft via Median Sternotomy,"
01-01-01
30-12-03
176.H
BioMarin | NTL06 | Neutralase:
“A Phase III Comparison of Neutralase to Protamine in Patients undergoing Primary Coronary Artery Bypass Graft Surgery”
01-01-01
12-12-03
503.A
Atricure, Inc. | CP2003-01 | RESTORE-SR:
“RESTORE-SR Study 2003-1: A Prospective Multi-center Study with Case Matched Controls to Evaluate the Safety and Efficacy of the AtriCure Bipolar System for the Treatment of Continuous Atrial Fibrillation as Adjunct Therapy to elective open heart surgery,”
05-02-04
01-12-06
505.B
The Medicines Company | TMC-CLV-03-03 | CABG Ca blocker ECLIPSE:
"Protocol No. TMC-CLV-03-03; A randomized, open label, prospective, parallel group comparison of CleveloxTM (clevidipine) versus nitroglycerin (NTG) for the treatment of hypertension as clinically required perioperatively (the perioperative period comprises the period immediately before surgery, during surgery, and after surgery until discharge from the intensive care unit [ICU])"
02-03-04
28-03-05
818.A
Medtronic, Inc. | | aneurysm-AAA- Medtronic:
Evaluation of Outcomes Between Endovascular Repairs of Small Versus Large Abdominal Aortic Aneurysms.
02-06-05
08-01-07
905.A
The Medicines Company | TMC-CLV-03-05 | nicardipine:
Evaluation of CleveloxTM In the Perioperative Treatment of Hypertension Assessing Safety Events (with Nitroglycerin as Active Comparator)
24-01-06
01-09-06
To make an appointment at any of our offices, please call (703)280-5858
Alexandria | Arlington | Falls Church | Fair Oaks | Manassas | Takoma Park | Warrenton | Woodbridge
